ClearBridge Advisors »

Intra Cellular Therapies shares owned by ClearBridge Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by ClearBridge Advisors from 13F filings

Historical chart of ClearBridge Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by ClearBridge Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $111M 1.6M 71.62
2023-09-30 $73M 1.4M 52.09
2023-06-30 $90M 1.4M 63.32
2023-03-31 $57M 1.0M 54.15
2022-12-31 $35M 659k 52.92
2022-09-30 $30M 651k 46.53
2022-06-30 $12M 205k 57.08
2022-03-31 $15M 240k 61.19
2021-12-31 $17M 331k 52.34
2021-09-30 $16M 433k 37.28
2021-06-30 $19M 473k 40.82
2021-03-31 $16M 476k 33.93
2020-12-31 $20M 622k 31.80
2020-09-30 $17M 647k 25.66
2020-06-30 $16M 626k 25.67
2020-03-31 $7.9M 511k 15.37
2019-12-31 $11M 318k 33.12
2019-09-30 $5.9M 785k 7.47